David Y. Takeda, Ph.D.
Affiliations: | 2005 | Harvard University, Cambridge, MA, United States |
Area:
Cell Biology, Biochemistry, Molecular BiologyGoogle:
"David Takeda"Mean distance: 15925.2
Parents
Sign in to add mentor| Anindya Dutta | grad student | 2005 | Harvard | |
| (Regulation of mammalian replication initiators during the cell cycle.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pomerantz MM, Qiu X, Zhu Y, et al. (2020) Prostate cancer reactivates developmental epigenomic programs during metastatic progression. Nature Genetics |
| Bellmunt J, Lalani AA, Jacobus S, et al. (2018) Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma. British Journal of Cancer |
| Sandoval GJ, Pulice JL, Pakula H, et al. (2018) Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis. Molecular Cell |
| Takeda DY, Spisák S, Seo JH, et al. (2018) A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer. Cell |
| Sandoval GJ, Pulice JL, Takeda DY, et al. (2016) Abstract 882: TMPRSS2-ERG drives global mistargeting of mammalian SWI/SNF (BAF) complexes in prostate cancer Cancer Research. 76: 882-882 |
| Dobi A, Petrovics G, Li H, et al. (2016) Abstract 140: LSAMP gene deletion is associated with rapid disease progression in prostate cancer of African American men Cancer Research. 76: 140-140 |
| Tan S, Petrovics G, Li H, et al. (2016) MP66-05 A NOVEL DELETION OF THE LSAMP GENE LOCUS ASSOCIATES WITH RAPID PROGRESSION OF PROSTATE CANCER AMONG AFRICAN AMERICAN MEN Journal of Urology. 195 |
| Petrovics G, Li H, Stümpel T, et al. (2015) A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men. Ebiomedicine. 2: 1957-64 |
| Pomerantz MM, Li F, Takeda DY, et al. (2015) The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis. Nature Genetics |
| Miyahira AK, Kissick HT, Bishop JL, et al. (2015) Beyond immune checkpoint blockade: new approaches to targeting host-tumor interactions in prostate cancer: report from the 2014 Coffey-Holden prostate cancer academy meeting. The Prostate. 75: 337-47 |